ML21119A166

Shine Medical Technologies, LLC, Request to Amend Construction Permit No. CPMIF-001

ML21119A166
Person / Time
Site:	SHINE Medical Technologies
Issue date:	04/29/2021
From:	Jim Costedio SHINE Medical Technologies
To:	Document Control Desk, Office of Nuclear Reactor Regulation
Shared Package
ML21119A165	List: ML21119A166 ML21119A168
References
2021-SMT-0057
Download: ML21119A166 (2)

Text

THIS LETTER CONTAINS SECURITY-RELATED INFORMATION IN ACCORDANCE WITH 10 CFR 2.390 April 29, 2021 2021-SMT-0057 10 CFR 50.90 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555

References:

(1) NRC letter to SHINE Medical Technologies, Inc., "SHINE Medical Technologies, Inc. - Issuance of Construction Permit for Medical Isotope Facility," dated February 26, 2016 (ML16041A473)

SHINE Medical Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 In accordance with 10 CFR 50.90, SHINE Medical Technologies, LLC (SHINE) hereby submits the enclosed request to amend Construction Permit No. CPMIF-001 (Reference 1) to permit SHINE to receive and possess certain radioactive materials necessary for the continued construction of the SHINE medical isotope production facility.

This submittal contains security-related information (SRI) which SHINE requests to be withheld from public disclosure in accordance 10 CFR 2.390(d). SRI was identified utilizing the guidance contained in Regulatory Issue Summary (RIS) 2005-31, Revision 1. provides a non-public version of the amendment request. SHINE requests that the NRC withhold Enclosure 1 from public disclosure under 10 CFR 2.390. provides a public version of the amendment request.

SHINE requests that the NRC approve this amendment request by August 31, 2021, to allow SHINE time to procure, receive, and install the requested radioactive material, to support timely construction of the SHINE facility.

If you have any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210-1735.

Enclosure 1 contains security-related information.

Withhold from public disclosure under 10 CFR 2.390.

Upon removal of Enclosure 1 this letter is uncontrolled.

101 E. Milwaukee Street, Suite 600 l Janesville, WI 53545 l P (608) 210-1060 l F (608) 210-2504 l www.shinemed.com

Document Control Desk Page 2 I declare under the penalty of perjury that the foregoing is true and correct.

Executed on April 29, 2021.

Very truly yours, James Costedio Vice President of Regulatory Affairs and Quality SHINE Medical Technologies, LLC Docket No. 50-608 Enclosures cc: Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health (w/o Enclosure 1)